Syndax Pharmaceuticals, Inc.
SNDX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$61 | -$72 | -$85 | -$94 |
| Dep. & Amort. | -$0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $12 | $14 | $10 | $12 |
| Change in WC | -$23 | -$27 | -$17 | $27 |
| Other Non-Cash | $2 | -$3 | -$3 | -$3 |
| Operating Cash Flow | -$71 | -$88 | -$95 | -$57 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$30 | -$92 | -$11 | -$376 |
| Inv. Sales/Matur. | $103 | $134 | $105 | $107 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $72 | $42 | $94 | -$269 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $6 | $1 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $1 | $347 |
| Financing Cash Flow | $6 | $1 | $1 | $347 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $8 | -$45 | -$0 | $21 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $109 | $154 | $154 | $133 |
| End Cash | $117 | $109 | $154 | $154 |
| Free Cash Flow | -$71 | -$88 | -$95 | -$57 |